Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
It acts on the appetite center in your hypothalamus, slows gastric emptying so food stays in your stomach longer, stimulates insulin release when blood sugar is elevated, and suppresses glucagon
Semaglutide is an FDA-approved GLP-1 receptor agonist, originally used to treat type 2 diabetes and now widely recognized for its ability to reduce appetite and promote weight loss (marketed as Wegovy and Ozempic)
doi: 10.2174/0115680096369817250407164352 182 KamilaSDey KoushikKChattopadhyayA
Thats the implication of a new study that examined health records of people with type 2 diabetes and opioid use disorder
/assets/images/provider/photos/2749086.jpeg)
GLP-1 (glucagon-like peptide-1) medications, including compounded versions like semaglutide, were originally developed for diabetes management, but they have become a breakthrough treatment for weight loss
If you are living with prostate cancer and also managing diabetes or obesity, ask your doctor whether GLP-1 medications might be appropriate for your overall healthnot as a cancer treatment, but as part of metabolic care
